San­doz's Hu­mi­ra biosim­i­lar nabs sig­nif­i­cant mar­ket share thanks to CVS part­ner­ship

The nine biosim­i­lars com­pet­ing with Ab­b­Vie’s megablock­buster Hu­mi­ra have tried every­thing from ex­act­ly im­i­tat­ing the lat­est ver­sion of brand-name Hu­mi­ra to tak­ing more than 80 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.